Showing results (1381-1390 of 1,515) with videos related to

Sort By:
Pageof 152
The EMBO Journal|February 7, 2009
Mislocalization of the MRN complex prevents ATR signaling during adenovirus infectionChristian T Carson, Nicole I Orazio, Darwin V Lee, et al.
Molecular Cell|March 13, 2012
Viral E3 ubiquitin ligase-mediated degradation of a cellular E3: viral mimicry of a cellular phosphorylation mark targets the RNF8 FHA domainMira S Chaurushiya, Caroline E Lilley, Aaron Aslanian, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 6, 2016
Family health history reporting is sensitive to small changes in wordingLiam S Conway-Pearson, Kurt D Christensen, Sarah K Savage, et al.
Journal of Alzheimer'S Disease : JAD|November 29, 2012
1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patientsMathew T Mizwicki, Guanghao Liu, Milan Fiala, et al.
Msphere|March 1, 2019
Genotypic and Phenotypic Diversity of Herpes Simplex Virus 2 within the Infected Neonatal PopulationLisa N Akhtar, Christopher D Bowen, Daniel W Renner, et al.
JAMA Network Open|August 6, 2021
Association of Thrombosis With Hypereosinophilic Syndrome in Patients With Genetic AlterationsOrly Leiva, Olesya Baker, Andrew Jenkins, et al.
Pediatrics|September 5, 2006
Youth tobacco use: a global perspective for child health care cliniciansAlexander V Prokhorov, Jonathan P Winickoff, Jasjit S Ahluwalia, et al.
Journal of Immigrant and Minority Health|April 10, 2019
Loneliness, Cardiovascular Disease, and Diabetes Prevalence in the Hispanic Community Health Study/Study of Latinos Sociocultural Ancillary StudySamantha A Foti, Tasneem Khambaty, Orit Birnbaum-Weitzman, et al.
The ISME Journal|November 29, 2007
Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileumMartin Baumgart, Belgin Dogan, Mark Rishniw, et al.
Neuro-Oncology|October 11, 2017
Phase II study of cabozantinib in patients with progressive glioblastoma: subset analysis of patients naive to antiangiogenic therapyPatrick Y Wen, Jan Drappatz, John de Groot, et al.
Pageof 152